This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More

Monsanto's Stock Is Still a Long-Term Growth Story

Stocks in this article: MONSYTDDBASFY

NEW YORK (TheStreet) -- Shares of agriculture giant Monsanto (MON), which are near their 52-week high, have been growing like weeds, closing Monday at $122.10, up nearly 5% for the year to date.

Although the YTD performance is modest, you'll be hard-pressed to find a better performer over the past four years. During that span, Monsanto stock has bloomed well over 160% compared to the Dow's 75% gain.

Monsanto will report third-quarter earnings Wednesday. With management operating on all cylinders, I would not be in a rush to sell the stock here, especially since management recently backed its full-year outlook, saying it expects to post a smaller loss in the fourth quarter compared to previous years.

Remarkably, the stock has risen amid consumer protests over Monsanto's genetically modified seeds. These issues have raised debates about genetically modified organisms (GMO) and the extent to which they should be disclosed on food labels.

With the company involved in so much controversy, investors want to know if Monsanto is still a good stock to own, especially after such a strong four-year run. I wouldn't sell just yet, however. There's still potentially 15% more growth left in these shares -- and that may be conservative.

Consider that when compared to rivals Syngenta (SYT) and DuPont (DD), Monsanto already enjoys a strong market position in areas like corn and soybeans. This is due (in part) to Monsanto's Roundup Ready and Intacta traits, which allow farmers to effectively control weeds while preserving the safety of their crops.

Now there are signs Monsanto's growth potential may be even better. In the most recent quarter, Monsanto soybean sales jumped 21%. This was preceded by a 16% jump in the January quarter.

This means that Monsanto's core seed operations are staring to do the heavy lifting. Investors should be encouraged by this. Combined with the dominant performance of the agricultural productivity business, which includes the aforementioned herbicides such as Roundup, investors can expect a sharp upward move in Monsanto's profits in the next 12 to 18 months. This should bode well for the stock.

Part of the optimism has to do with a recent report from the U.S. Department of Agriculture that projects a 6% jump in soybean acreage for 2014, which would be a record at 81.5 million.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,827.75 +12.81 0.07%
S&P 500 2,072.83 +5.80 0.28%
NASDAQ 4,787.3170 +29.0650 0.61%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs